Demographics, clinical characteristics, and treatment patterns for patients with BRCA mutated, HER2-negative early stage breast cancer: a CancerLinQ® real-world US study
2021
Mokiou S, DeClue RW, Gautam S, Herms L, Jiang M, Sun P, McCutcheon S, Stearns V, Nunes MR